Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst. F-Prime Capital, LUX Capital, ...
Anna Monaco has been building AI agents since before the term “AI agents” was even a thing. After building numerous chatbots, she started looking for other types of interfaces that made sense for AI ...
A new tech startup wants to disrupt the clinical trial process and landed $203 million to help scale up its technology. Paradigm, a clinical trials data and patient-matching platform, aims to open up ...
Devon Schiff has also landed at Paradigm following a departure from Verve, where Weinstein was previously CEO. By Mia Galuppo, Borys Kit After leaving Verve last month, Bill Weinstein and Devon Schiff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback